Private Capital Group, LLC Fate Therapeutics Inc Transaction History

Private Capital Group, LLC

  • $133 Million
  • Q2 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022
SELL
$17.78 - $42.39 $320 - $763
-18 Closed
0 $0
Q1 2022

Apr 21, 2022
SELL
$29.67 - $60.28 $178 - $361
-6 Reduced 25.0%
18 $1,000
Q4 2021

Jan 24, 2022
BUY
$47.84 - $64.34 $574 - $772
12 Added 100.0%
24 $1,000
Q3 2021

Oct 13, 2021
BUY
$59.27 - $95.73 $711 - $1,148
12 New
12 $1,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $215M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email